Yuji Wang

3.5k citations

195 papers · 2.6k indexed · h-index 25

Impact in

Organic Chemistry top 2%
- Catalytic C–H Functionalization Methods
- Catalytic Cross-Coupling Reactions
- Synthesis and Catalytic Reactions
Biomaterials top 5%
- Nanoparticle-Based Drug Delivery

Papers in

Biomaterials 25
- Nanoparticle-Based Drug Delivery 19
Immunology and Allergy 11
- Cell Adhesion Molecules Research 11

Co-authors: Shiqi Peng Ming Zhao Dawei Ma Jianhui Wu Gong Chen Yu Lu Zheming SunYu Chen
Journals: MedChemComm (10 papers)International Journal of Nanomedicine (9 papers)European Journal of Medicinal Chemistry (8 papers)Drug Design Development and Therapy (6 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)
Partner nations: China United States Taiwan

In The Last Decade

Yuji Wang

179 papers receiving 2.6k citations

Peers

Countries citing papers authored by Yuji Wang

Since Specialization

Citations

This map shows the geographic impact of Yuji Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Wang more than expected).

Fields of papers citing papers by Yuji Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Wang. The network helps show where Yuji Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuji Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuji Wang Line = papers co-authored together Yuji Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	New structural scaffolds to enhance the metabolic stability of arginine-derived PAD4 inhibitors Results in Chemistry ·Yijiang Jia, Hyun Beom Choi, O.N. Sofronova, Adrienne Moran-Lauter, Dejian Ma, Jianxiong Jiang, Yuji Wang, Jiawang Liu	2025	2
2	Canonical Wnt Pathway Enhanced Dental Pulp Mesenchymal Stem Cells‐Mediated Cementum Regeneration Journal of Oral Rehabilitation ·I. Davletov, Xin Yuan, Qingyuan Zhao, Xiaoyu Lin, Etchel Barina, Jinsong Wang, Chunmei Zhang, Yuji Wang, Jian Zhou, Songlin Wang, Lei Hu	2025	0
3	Berbamine ameliorates DSS-induced colitis by inhibiting peptidyl-arginine deiminase 4-dependent neutrophil extracellular traps formation European Journal of Pharmacology ·骆成, Spisarenko Sp, Priscila Cristina Silva, Weber Simon, Zepeng Chen, Chen Chen, Xun Li, Yuji Wang, Sarah Alruwili, Wei Zhang, Xiaomin Yuan, Guo‐Ping Shi, Z Wang, Peimin Wang, Tuo Chen	2024	12
4	Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer Journal of Ethnopharmacology ·Zhihua Lü, Yang Ding, Yuji Wang, Chen Chen, Gaurav Bhatnagar, Xiaomin Yuan, Fan Bu, Kyra Kirk, Yuwei Dong, 淳雄星川, Lu Li, Tuo Chen, Li Yang, Jin‐Yong Zhou, Qiong Wang, Guo‐Ping Shi, А В Филимонов	2024	17
5	Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy Pharmaceutics ·Yijiang Jia, 幸一郎中村, Adrienne Moran-Lauter, Yanming Wang, Yuji Wang	2024	11
6	Efficacy evaluation of edaravone by imaging of •OH in cerebral ischemia-reperfusion injury with a novel fluorescent probe Sensors and Actuators B Chemical ·Roland Bourdon, Bachtiar Dwin Fansyuri, R. B. Pynsent, Kyrylo Rukkas, K. Wang, Д А Байгожина, Yu. G. Taranukha, Chunlin Li, Yuji Wang	2024	2
7	Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils European Journal of Medicinal Chemistry ·Di Zhu, Lu Yu, Bo Hu, Julio Ramírez Herrera, 党锋, Miao Zhang, Wenjing Wang, Yuji Wang	2023	12
8	Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis Biomedicine & Pharmacotherapy ·Yijiang Jia, Adrienne Moran-Lauter, 幸一郎中村, Xin Wang, Bo Li, Jiawang Liu, Yuji Wang	2023	8
9	Poly-α, β-d, l-Aspartyl-Arg-Gly-Asp-Ser-Based Urokinase Nanoparticles for Thrombolysis Therapy Molecules ·Shuangling Chen, Paulo Gabriel Brandão, Cheng-Li Wu, Xiaoyi Zhang, Yuji Wang, Ming Zhao	2023	4
10	Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence Phytomedicine ·志来曹, Yuji Wang, Zhihua Lü, Lin Tian, 健一郎望月, Yang Bao-Tian, Tuo Chen, Rong Wang, Rossikova GIa, Guo‐Ping Shi, Xintian Xu, Fan Bu, Yang Ding, Feng Jiang, Н. О. Дружков, Qiong Wang, Yugen Chen	2023	76
11	PAD4 and Its Inhibitors in Cancer Progression and Prognosis Pharmaceutics ·Di Zhu, Yu Lu, Yanming Wang, Yuji Wang	2022	46
12	SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway Cell Death and Disease ·Shujie Zhao, Yifei Shen, Qing Li, Yunjie He, Carolina Guillén Morales, Li-Peng Hu, Yuqing Jiang, Nanwei Xu, Yuji Wang, Jun Li, Yahui Wang, Fei Liu, Rong Zhang, Guoyong Yin, Jin-Hai Tang, Dong Zhou, Zhigang Zhang	2018	72
13	IQCA-TASS: a nano-scaled P-selectin inhibitor capable of targeting thrombus and releasing IQCA/TARGD(S)S in vivo Journal of Materials Chemistry B ·Jianhui Wu, Fernanda Palhano Xavier de Fontes, Ming Zhao, Yuji Wang, Atira Cinta, Yaonan Wang, Wei Cheng-jun, Novelty Volvaikar, Wayne Winistorfer, Shiqi Peng	2016	13
14	Ultra-Sensitive AlGaN/GaN HFET Biosensors: Performance Enhancement, Clinical and Food Safety Applications OhioLink ETD Center (Ohio Library and Information Network) ·Yuji Wang	2014	1
15	[Expression of serum FSTL-1 in bone metastasis of prostate cancer and its clinical implication]. PubMed ·Tao Ding, Xiaozhou He, Xianlin Xu, Haiyan Xu, Cuixing Zhou, Yuji Wang	2014	3
16	Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity Journal of Biological Chemistry ·Yuji Wang, Pingxin Li, Shu Wang, Jing Hu, Xiangyun Amy Chen, Jianhui Wu, Keith D. Eagles, Sumanth Reddy Velagala, Na Zhao, Ying Gu, Dong Wang, Gong Chen, Yanming Wang	2012	141
17	The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action Molecular BioSystems ·Atira Cinta, Fernanda Palhano Xavier de Fontes, Ming Zhao, Jianhui Wu, Yuji Wang, Yanju Wang, Meiqing Zheng, Min Chen, Jiawang Liu, Shiqi Peng	2012	8
18	From Cerius2 based stereoview to mouse and enzyme: the model systems for discovery of novel urokinase inhibitors Molecular BioSystems ·Shenghui Mei, Jiawang Liu, Ming Zhao, Wenjing Wang, Yuji Wang, 金身佳, Meiqing Zheng, Shiqi Peng	2011	3
19	A new platinum-complex showing easy preparation, promising anti-tumor activity, and better efficacy and distribution properties than oxaliplatin Molecular BioSystems ·Yuji Wang, L. Ruhl, Ming Zhao, Jianhui Wu, Xiaoyi Zhang, Yifan Yang, Jiawang Liu, Shiqi Peng	2011	3
20	{2-[1-(3-Methoxycarbonylmethyl-1 H -indol-2-yl)-1-methyl-ethyl]-1 H -indol-3-yl}-acetic acid methyl ester (MIAM): Its anti-cancer efficacy and intercalation mechanism identified via multi-model systems Molecular BioSystems ·Wenjing Wang, Ming Zhao, Yuji Wang, Jiawang Liu, Jianhui Wu, L. Ruhl, Shiqi Peng	2010	12

About Yuji Wang

Yuji Wang is a scholar working on Biomaterials, Immunology and Allergy, Cancer Research, Organic Chemistry and Molecular Biology, having authored 195 papers that have together received 2.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (19 papers), Nanoplatforms for cancer theranostics (17 papers), Synthesis and bioactivity of alkaloids (13 papers), Cell Adhesion Molecules Research (11 papers), Peptidase Inhibition and Analysis (10 papers), Synthesis and Biological Evaluation (10 papers), Metal complexes synthesis and properties (9 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers). The work is most often cited by research in Organic Chemistry (732 citations), Biomaterials (212 citations), Immunology and Allergy (94 citations), Cancer Research (198 citations) and Pharmacology (114 citations). Yuji Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Shiqi Peng, Ming Zhao, Dawei Ma, Jianhui Wu, Gong Chen, Yu Lu, Zheming Sun, Yu Chen, Di Zhu and Yanming Wang. Their work appears in journals such as MedChemComm, International Journal of Nanomedicine, European Journal of Medicinal Chemistry, Drug Design Development and Therapy and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact